SI1656391T1 - Modified human igf-1r antibodies - Google Patents

Modified human igf-1r antibodies

Info

Publication number
SI1656391T1
SI1656391T1 SI200431532T SI200431532T SI1656391T1 SI 1656391 T1 SI1656391 T1 SI 1656391T1 SI 200431532 T SI200431532 T SI 200431532T SI 200431532 T SI200431532 T SI 200431532T SI 1656391 T1 SI1656391 T1 SI 1656391T1
Authority
SI
Slovenia
Prior art keywords
antibodies
modified human
human igf
igf
modified
Prior art date
Application number
SI200431532T
Other languages
Slovenian (sl)
Inventor
Bruce David Cohen
Vahe Bedian
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority claimed from PCT/IB2004/002555 external-priority patent/WO2005016967A2/en
Publication of SI1656391T1 publication Critical patent/SI1656391T1/en

Links

SI200431532T 2003-08-13 2004-08-03 Modified human igf-1r antibodies SI1656391T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49520003P 2003-08-13 2003-08-13
PCT/IB2004/002555 WO2005016967A2 (en) 2003-08-13 2004-08-03 Modified human igf-1r antibodies
EP04744197A EP1656391B1 (en) 2003-08-13 2004-08-03 Modified human igf-1r antibodies

Publications (1)

Publication Number Publication Date
SI1656391T1 true SI1656391T1 (en) 2010-12-31

Family

ID=43416259

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431532T SI1656391T1 (en) 2003-08-13 2004-08-03 Modified human igf-1r antibodies

Country Status (1)

Country Link
SI (1) SI1656391T1 (en)

Similar Documents

Publication Publication Date Title
IL173273A0 (en) Modified human igf-1r antibodies
EP1616881A4 (en) Anti-mpl antibodies
IL175608A0 (en) Antibodies
ZA200604074B (en) Anti-IGFR1 antibody therapeutic combinations
PT1599504E (en) Modified antibody
EP1494693A4 (en) Cripto-specific antibodies
EP1648512A4 (en) Anti-cd19 antibodies
PL375405A1 (en) Antibodies
EP1572131A4 (en) Antibody therapy
IL173557A0 (en) Variable antibodies
IL175935A0 (en) Solid forms of anti-egfr antibodies
HK1087722A1 (en) Interleukin-10 antibodies
PT1549341E (en) Tissue factor targeted antibodies as anticoagulants
SI1587542T1 (en) Use of anti-cd100 antibodies
EP1631315A4 (en) Antibodies which bind human cxcr3
IL172511A0 (en) Specific human antibodies
EP1598368A4 (en) Anti-pci neutralizing antibodies
GB0306618D0 (en) Antibody
SI1656391T1 (en) Modified human igf-1r antibodies
GB0226878D0 (en) Antibodies
HK1209139A1 (en) Modified antibody
GB0325391D0 (en) Human monoclonal antibodies
GB0329711D0 (en) Antibodies
GB0317974D0 (en) Novel antibodies
GB0203018D0 (en) Antibodies